+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Atrial Fibrillation Market to Reach US$14.8 bn by 2019, Propelled by Rising Prevalence of Lifestyle Diseases

Posted on Dec 15, 2015

Transparency Market Research (TMR) has recently published a market study on the global atrial fibrillation market, estimating the market to expand at a CAGR of 13.40% during the period from 2013 to 2019 and reach a market value of US$14.8 bn by the end of the forecast period. The market stood at US$6.1 bn in 2012.The report, titled “Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, states that the rapid increase in the geriatric population across the world, coupled with the rising prevalence of various disorders such as obesity and hypertension, is propelling the global atrial fibrillation market significantly.


Browse Full Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Report at https://www.transparencymarketresearch.com/atrial-fibrillation-market.html

The report segments the global atrial fibrillation market on the basis of the type of treatment. The worldwide market is broadly classified into the markets for pharmacological and non-pharmacological treatments. Anti-coagulant drugs and anti-arrhythmic drugs are the two main segments of the pharmacological treatment market, which dominates the overall market for atrial fibrillation. The frequent administration of drugs, owing to their cost efficiency when compared to a non-pharmacological procedure, has stimulated this market segment extensively.

Analysts expect the market for pharmacological treatments to maintain its dominance over the forecast period. The segment is likely to increase its market share to 55% by the end of the forecast period. The launch of new and advanced drugs such as the highly effective anti-coagulants rivaroxaban and dabigatran is anticipated to boost the market segment significantly.According to the report, North America, Asia Pacific, Europe, and the Rest of the World are the key regional markets for atrial fibrillation. Among these, the North America atrial fibrillation market dominates the global market with a majority share and is closely followed by Europe and Asia Pacific. The high prevalence of atrial fibrillation in this region is the key factor driving this market in North America.


Apart from this, the soaring disposable income of patients in the region, coupled with a robust reimbursement infrastructure, are some other prominent reasons for the impressive development of the North America market for atrial fibrillation.The Asia Pacific market for atrial fibrillation is projected to register the highest CAGR during the forecast period. The increasing incidence of atrial fibrillation in China is likely to fuel the market to a large extent. The introduction of novel reforms related to healthcare and the rapid development of the economy are also expected to support the growth of this regional market significantly, says the market study.

The competitive landscape of the global atrial fibrillation market has also been presented in this report based on the analysis of company profiles of major players. AtriCure Inc., Boehringer Ingelheim GmbH, Biosense Webster Inc., Boston Scientific Corp., CardioFocus Inc., Bristol-Myers Squibb Corp., Endoscopic Technologies Inc., St. Jude Medical Inc., Sanofi Aventis, and Johnson and Johnson Ltd. are the key participants operating in the worldwide market for atrial fibrillation, states the research report.

The global atrial fibrillation market is segmented into:

By Types of Treatments

    • Pharmacological Treatment

      • Anti-Arrhythmic Drugs
      • Anti-Coagulant Drugs
    • Non-Pharmacological Treatment

      • Catheter Ablation

        • Radiofrequency Based
        • Cryoablation Based
        • HIFU (High Intensity Focused Ultrasound) Based
        • Microwave Based
        • Laser Based
      • Maze Surgery
      • Electric Cardioversion

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Browse : Our new press releases https://www.transparencymarketresearch.com/pressrelease/global-atrial-fibrillation-market.htm

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com


Back To Top